The subcutaneous administration route of epoetin: advantages, pain at the injection site and patient acceptance.
Vey
S N
SN
Ringoir
S
S
D004305:Dose-Response Relationship, Drug; D004921:Erythropoietin / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D006801:Humans; D007262:Infusions, Intravenous; D007279:Injections, Subcutaneous / Q000009:adverse effects; D010146:Pain / Q000209:etiology; D010342:Patient Acceptance of Health Care; D011994:Recombinant Proteins / Q000008:administration & dosage
D011994:Recombinant Proteins; D004921:Erythropoietin